跳至主要内容
临床试验/JPRN-UMIN000013039
JPRN-UMIN000013039已完成未知

A multicenter clinical trial of the effect of raloxifene hydrochloride for the prevention of health care problems caused by bilateral oophorectomy due to endometrial cancer - A multicenter clinical trial of the effect of raloxifene hydrochloride after endometrial cancer surgeries.

Osaka University Graduate School of Medicine, Department of Obstetrics and Gynecology0 个研究点目标入组 200 人开始时间: 2014年1月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25years-old 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Patients who refuse participation in this study. Patients who had taken bisphosphonates, estrogen or progestin within the previous 1 year, or vitamin D3, vitamin K2, or ipiriflavone within previous 3 months. Patients who raloxifene, alfacalcidol, or Calcium L-Aspartate Hydrate is contraindicated for. Patients whose lumber BMD was above +2.5 S.D. at the enrollment.

研究者

发起方
Osaka University Graduate School of Medicine, Department of Obstetrics and Gynecology

相似试验